40 Years of Research, Education & Support Summer 2015 The Tribulations and Triumphs of Transplant: Maggie Williamson’s Journey By Maggie Williamson and Siri Vaeth Dunn, MSW Maggie Williamson was diagnosed with cystic fibrosis (CF) at 13 months old. In the spring of 2013, Maggie was 24 years old, married and living in California, when she experienced a severe downturn in her health. She was listed for transplant, and nearly 13 months later, received the gift of new lungs. In a recent interview, Maggie spoke candidly about the unexpected tribulations and powerful triumphs post-transplant. Tell me about the weeks prior to transplant. That was my toughest month. I was not working or in school; I only concentrated on my health. I got extremely sick and was put on full-time oxygen. I pretty much did nothing – even driving and running errands were too hard. I started ordering groceries online and the rare times Tom and I went out, I used a wheelchair. It was very hard for Tom to watch me deteriorate. What was it like to take your first breath with your new lungs? I never had that “aha” moment with my breath, as my lungs were slow to expand, but other physical changes brought tears to my eyes. Seeing my oxygen saturation reach 100 percent two days after surgery was a moment I won’t forget. I marveled at walking down the hospital hallway ten days out of surgery and standing tall for the first time after years of hunching over due to heavy breathing. The first time I looked in the mirror and saw the huge scar running down my chest I burst into tears, recognizing my life had changed for good. It was such a joyful Maggie WIlliamson canoeing on her 27th birthday, five months post transplant moment to know I was given the ultimate gift of life because of my donor. It was a profoundly grateful moment. Tell me about Tom and your journey as a couple. I met Tom in 2009, when I was 21. I was more independent in our first three years, but during the last three, Tom has had a much bigger Continued on page 4 Measuring CFTR Function in Humans with a Simple Sweat Test By Jeffrey Wine, PhD Jeffrey Wine, PhD As everyone in the cystic fibrosis (CF) community knows, CF treatment is being revolutionized. For the first time, defective CFTR molecules, the root cause of all CF symptoms, can be targeted directly. Remarkably, the new medicines are easily taken daily pills that fix CFTR in all parts of the body – not only the lungs. Ivacaftor (Kalydeco) is the first such medicine; better follow-on drugs are being developed. These exciting research breakthroughs have created a huge surge of hope, but also great impatience to get these life-saving drugs as soon as possible. Drug discovery is accelerating because innovations such as robotic testing allow millions of compounds to be screened on cells grown in the laboratory. But it is still necessary to test potential drugs in humans to look for side effects and to see how well they work. Continued on page 10 CFRI Community Summer 2015 Editorial Chief Sue Landgraf Editors Bridget Barnes Siri Vaeth Dunn, MSW Contributing Writers Bridget Barnes Isa Stenzel Byrnes, MSW, MPH Mary Convento Siri Vaeth Dunn, MSW Bill Hult Sue Landgraf John Mark, MD Jane Mitchell Maggie Williamson Jeffrey Wine, PhD Layout and Design Marina Michaelian Ward Board of Directors Bill Hult, President Jessica Martens, Vice President Mike Roanhaus, Secretary Oscar Flamenco, CPA, Treasurer Brad Baugh, JD Francine Bion Elyse Elconin-Goldberg Doug Modlin, PhD Kristin Shelton, RRT Executive Director Sue Landgraf Programs & Outreach Manager Siri Vaeth Dunn, MSW Programs & Outreach Supervisor Mary Convento Letter from the Executive Director “Alone we can do so little, together we can do so much..” Dear Friends, — Helen Keller What an exciting year! CFRI has experienced a period of unprecedented growth in every sense of the word. In addition to increased research funding, we have launched numerous new programs, including the Partners in Living Initiative, which offers wonderful support to our community. The successful Pediatric Conference and Mindfulness Based Stress Reduction sessions Sue Landgraf have concluded, but a Caregivers Support Group and counseling services are available to individuals nationwide through the Cystic Fibrosis Quality of Life Program, A Living Legacy of Peter Judge. I strongly encourage those touched by cystic fibrosis (CF) to take advantage of these resources. They will strengthen you, and in turn strengthen our community. We are gearing up for the 28th National Cystic Fibrosis Family Education Conference, which will be held July 31 to August 2, 2015 in Redwood City, California. Some of the most noted experts in the field will travel from New York, Ontario (Canada), Washington, New Jersey, and throughout California to address topics including the CF pipeline, mental health and adherence, transition, and the treatment of emerging pathogens. We are shifting the schedule this year to expand access to this vital information. The conference will conclude on Sunday with a new sit-down luncheon featuring an exciting multi-media presentation from a dynamic member of the CF community, as well as a wide array of support groups, yoga, art, and journaling workshops. I look forward to seeing everyone there. I also extend a warm invitation to adults with CF and their friends and families to attend the CF Summer Retreat, “Animate Your Summer!,” from August 2 to August 9, 2015 at Vallombrosa in Menlo Park, California. Thanks to CFRI’s stringent infection control policies, those with CF have a rare opportunity to come together for educational presentations, camaraderie, support, and fun. We have so much to accomplish together as a community. We are still seeking the elusive cure for our loved ones with CF, and eagerly await the arrival of powerful new drugs that treat the underlying defect in those living with the double delta F508 mutation. While I believe that alone each of us can achieve important goals, I agree with Helen Keller’s observation that, “together we can do so much.” I am delighted to do so much in partnership with you. Programs & Operations Associate Warmly, Programs & Operations Assistant Sue Landgraf | Executive Director and mother of an adult daughter with CF Scott Wakefield France Redmayne CFRI Community is published and distributed to friends of CFRI for free. Send address corrections and other correspondence to CFRI: 1731 Embarcadero Road, Suite 210 Palo Alto, CA 94303 News from the Board Dear CFRI Community, I hope that this finds you well. As we approach the halfway mark for 2015, I am pleased to share that CFRI is continuing the growth trend that began in 2014. Our recently completed audit shows that we are fiscally strong. In fact, due to the success of our fundraising efforts last year, our revenue growth in 2014 exceeded our 2013 total by nearly 34%, allowing us to provide new education and support programs and increase our research awards. We provided a second year of funding to five CF researchers from 2013 Phone: Toll Free 1.855.cfri.now (1.855.237.4669) Fax: 650.404.9981 Email: cfri@cfri.org Website: www.cfri.org With our permission, you may reproduce original information from this newsletter with credits to CFRI Community and the author. 2 Bill Hult, President Continued on page 3 cfri | Summer 2015 Cystic Fibrosis and Complementary and Alternative Medicine: An Integrative/Holistic Approach John D. Mark, MD For those with cystic fibrosis (CF), the current system of conventional healthcare can be enormously frustrating. Rather than simply keeping their symptoms in check, many people with CF seek to reclaim wellbeing and vitality. The holistic approach does not reject conventional medicine, but considers the entire picture of health and uses the best and most appropriate options for healing. Complementary and alternative medicine (CAM) is increasingly used by patients with CF. CAM covers a broad range of healing philosophies, approaches and therapies that can be used alone, in combination with other alternative therapies, or along with conventional medicine. The major classes of CAM include alternative medical systems such as homeopathic, naturopathic, traditional Chinese, and Ayurvedic medicine. Mind-body medicine incorporates interventions that enhance the body’s capacity to affect bodily functions and symptoms. Biologically based therapies include dietary supplements, foods, herbs, vitamins, and natural substances. Manipulative and body-based methods include osteopathy, chiropractic and massage. Energy therapies include biofield therapies and bio-electromagnetic therapy. Complementary and alternative therapies can be very helpful to those with CF followed by mind-body medicine (49%) and manipulative therapies (14.5%). As a starting point, making lifestyle choices that include avoidance of allergens, tobacco smoke and air irritants, good sleep hygiene, and regular exercise can have a positive impact upon one’s health. Exercise is a valuable tool for CF patients as it often stimulates coughing, thereby helping with airway clearance while improving cardiovascular health. When planning one’s In a study of CAM use in children and adults exercise routine, seek advice from your CF with CF, 75% of patients used some form of care team. alternative medicine, and over two-thirds of the respondents felt CAM was useful. Nutrition is vitally important to CF health. The majority (53%) used biologically based Because diet is the major source of antitherapies such as dietary supplements, oxidants, patients with cystic fibrosis should maintain a high calorie, high protein diet, while increasing their consumption of fruits and vegetables, omega-3 fatty acids, and other antioxidant-rich foods including fish, while decreasing omega-6 fatty acid intake. Mind-body therapies or cognitive behavioral therapies include relaxation therapy, breathing exercises, biofeedback, hypnosis, and guided imagery, and are based on the theory that the nervous system’s response to stress and strong emotions increases cytokine levels that are contributors to airway inflammation. Self hypnosis, breathing exercises, yoga, and relaxation techniques have all been studied in CF and indicate that Continued on page 5 News from the Board Continued from page 2 and funded six new CF researchers in 2014, stability as well as its flexibility to respond bringing our total to 11 researchers in 2014 to our CF community’s emerging needs. – an increase of four. Last year the Board of Directors partiThe credit for this must be shared amongst cipated in an in-depth strategic planning process. A summary of the resulting our entire CFRI community, from donors, to corporate and foundation funders, to plan is included in the attached Annual Report. I encourage you to read this members of the Board, and our agency document, which will help to guide our staff. We are fortunate to have the organizational leadership of Sue Landgraf, actions in the year ahead as we continue to embody our tagline, “Research for and I can assure you that the Board of Directors is fully committed to both CFRI’s Living ~ Partners for Life.” You are a part cfri | Summer 2015 of this strategic plan. Every member of our community has a role to play. I thank you for your engagement and support, as we seek to improve and enhance the lives of those with cystic fibrosis. Peace and good health, Bill Hult | Board President 3 The Tribulations and Triumphs of Transplant Continued from front cover role in taking care of me. My mom flew in from Chicago to help out for the first two months post transplant, and my dad and brother came out to help for as long as their work allowed, but since then it has been all on Tom. As most parents know, being a caregiver is extremely hard. Going through something as major as a transplant takes its toll on everyone. We talk a lot about how our situation is not a “normal” couple situation. This journey has been difficult. I don’t sugar coat it because I think more couples should speak out about the challenges chronic illness brings to their relationship. How hard was the recovery? The initial recovery was almost too easy. For me, the hard work came when I was discharged. Going in for hospital appointments three to four days a week started to take its toll and became exhausting and overwhelming. Things have settled a bit, but I would be okay with not seeing a hospital for a few months. What was unexpected post transplant? We have this great miracle, but a lot of new problems come with it. I was an expert in my CF, but still don’t have much of a clue about this new disease and body that I live with. Many people think the only concern is rejection of the lungs, but there are other serious complications. In addition to a (now healed) wound and blood infection, pneumothorax, and frightening virus, I have a lot of stomach issues because nerves that help with digestion were severed during surgery. People who don’t know much about transplant perceive me as cured. This is far from a cure. It is a way to prolong and improve my quality of life, but I still have a chronic illness. What have the greatest challenges been post transplant? Learning a new normal. Rediscovering life. I was essentially reborn, and am revisiting the developmental stages. In the beginning I needed help with everything like a newborn. I feel like I’m in my preteen phase now, testing limits and boundaries, gaining independence, and trying to ignore the fact that I occasionally still need support. Prednisone gives you a false sense of reality, and I’ve come up with crazy ideas like wanting to rock climb four months post-transplant. Most significantly, it has been a very long time since I’ve had a focus besides my health, and I feel a bit lost as to where I will go in life. Defining myself outside of sickness will be my biggest challenge. Maggie and Tom Williamson, soon afer her transplant. What advice do you have for others who are pondering when to get listed? Listen to your gut. After I was approved to be listed I gave myself an extra three months, and at that point my mind and body were ready. Everyone is different so don’t read the bad stories and think it will happen to you. This truly is each person’s unique journey. And remember, you have nothing to lose. At end stage disease there is nowhere to go but down, and transplant offers the hope of a better quality of life. What has been a “wow” moment for you post transplant? Dancing and singing! Also, the endurance I have. Being able to take a shower, get dressed, and do my hair without having to stop for long periods of time between each task. Who knew you could wash your hair and shave your legs in the same showering session!? Tom and I are moving to England in the near future – something that was unimaginable just a few months ago. Oftentimes it hits me that these are not my lungs. That will hit me like a ton of bricks some days, and it just brings me to a quiet place of sheer gratitude. I am living because of someone else. That is the biggest “wow” moment that keeps coming back to me. Funding Inspired CF Research David Cornfield, MD 4 Carlos Milla, MD CFRI’s Board of Directors has awarded research grant funding to two Stanford physicians and their post-doctoral research fellows through CFRI’s Elizabeth Nash Memorial Fellowship Program. Principal Investigator, David Cornfield, MD, Professor of Pulmonary Medicine and Chief, Pulmonary and Critical Care Medicine at Lucile Packard Children’s Hospital Stanford, along with his post doctoral fellow, Michael Tracy, MD, have received a $40,000 grant for their CF research project, while Carlos Milla, MD, Associate Professor of Pediatrics (Pulmonary Medicine) Stanford University Medical School, and his post-doctoral fellow, Andrey Malkovskiy, PhD, were granted $40,000 for their research project. CFRI is honored to support their inspired research. cfri | Summer 2015 Breakthrough Therapy for Most Common CF Mutation Recommended for Approval by FDA Subcommittee By Bridget Barnes In May, the Pulmonary-Allergy Drugs Advisory Committee of the US Food and Drug Administration (FDA) voted 12 to 1 in favor of recommending that the FDA approve a single pill combining the drugs Ivacaftor and Lumacaftor for the treatment of cystic fibrosis in patients age 12 years and older who have two copies of the F508del mutation. Developed by Vertex Pharmaceuticals and targeting the root cause of the disease, the new combination, called “Orkambi,” combines Ivacaftor, a “potentiator,” that improves the transport of chloride ions across the cell membrane, and Lumacaftor, a “corrector,” that moves defective CFTR protein to the proper place in the airway cell membrane and improves its An Integrative/Holistic Approach Continued from page 3 they may decrease shortness of breath and chronic symptoms such as cough, and may help with lung expansion. While herbal supplements are the most common CAM therapy reportedly used by those with CF, their use is consistently under-reported to CF physicians. This is cause for concern, because some herbs may have negative interactions with conventional medications and other supplements. Dietary supplements do not need to meet the same safety and effectiveness standards as pharmaceutical medications, and there are reports of some supplements being contaminated with metals, unlabeled prescription drugs, and microorganisms, or containing none of the herbs listed on their labels. Studies of antioxidants such as Vitamin C, selenium, and fish oil/omega 3 fatty acids used by those with CF have had variable results. Creatine has been studied in CF and shown to improve short-term muscle strength. Other beneficial dietary supplements for CF include vitamins A, B, D, and E, calcium, magnesium, ginger, gingko, garlic, lipoic acid, baker’s yeast, green tea, and ginseng. Probiotics are beneficial for those with CF, as they may cfri | Summer 2015 function as a chloride channel. Phase 3 clinical trials were conducted at approximately 200 clinical trial sites in North America, Europe and Australia, and more than 1,100 people with two copies of the F508del mutation, ages 12 and older, participated in the studies. The trials tested two different doses of Ivacaftor and Lumacaftor. Compared with those on placebo, participants who took the combination treatment showed statistically significant and consistent improvement in lung function and other important health measures, including weight gain, and a reduction in the rate of pulmonary exacerbations. Sue Landgraf, CFRI’s executive director, travelled to Maryland to address the Pulmonary-Allergy Drugs Advisory Commit- A Vertex scientist in the lab tee during oral presentations, along with members of the nationwide CF community. She noted that the testimony of those living with the disease was extremely impactful, adding, “The committee’s recommendation for approval brings us one step closer to a drug therapy that targets the double Delta F508 mutation. For now, this is the closest thing to a cure that we have. CFRI was honored to be a part of this momentous day.” The application will now go to the FDA for approval, with an estimated announcement by July 5th. help improve intestinal barrier function and modify the immune response. Taurine, an essential amino acid, may improve fat absorption and weight gain in CF, while N-acetylcysteine (NAC) may soon be a standard of care for the antioxidant properties it provides. Manipulative therapies include massage, osteopathic and chiropractic manipulation. Small studies of children with CF and their parents have found that massage therapy led to a reduction in anxiety, improved mood and increased peak flow measurements. Traditional Chinese Medicine is based upon the belief in an unseen vital energy, or “qi,” that affects patients’ health. This energy’s flow is monitored and manipulated using acupuncture, Asian herbs, diet, and physical therapy. One study at Boston’s Children’s Hospital showed acupuncture to be effective in decreasing pain complaints in patients with CF. Homeopathic medicine utilizes the “Law of Similars,” in which small, highly diluted quantities of medicinal substances are given to cure symptoms, when the same substances given at higher or more concentrated doses would actually cause those symptoms. In order to put all the pieces of one’s CF care together, it is useful to develop an John D. Mark, MD Integrative Medical Plan for CF, which includes discussions about medications, adherence, lifestyle changes including exercise and diet, supplements (including herbal remedies), and the use of Traditional Chinese Medicine, manipulative therapies and/or homeopathy. The most important component is education and teamwork in regard to all aspects of the healthcare plan. If the CF medical team sets CAM in opposition to conventional medicine, it could create a barrier to optimal self-care management. The use of complementary and alternative medicine does not indicate unrealistic expectations of a cure; rather, it demonstrates a desire to have better control and self-management of one’s chronic condition. 5 The Jessica Fredrick Memorial CF Research Challenge Circle: Supporting the Search for a Cure in Memory & In Honor of Those with CF Our “In Memory of ” and “In Honor of ” pages provide the opportunity to honor a person, family, or special event, or to remember a loved one. “Strength does not come from physical capacity. It comes from an indomitable will.” — Gandhi Jessica Fredrick CFRI is very pleased to have broadened its research funding in 2014, thanks to members of our Jessica Fredrick Memorial CF Research Challenge Circle, and the generosity of those who contributed to the fund. CFRI needs your help to continue this forward momentum. Please join with us to improve the lives of those battling cystic fibrosis. The Research Challenge Circle has set a goal to raise $80,000 in 2015, to be used to match contributions designated for research. Please consider joining the Circle, or making a gift to the Research Challenge Fund. Unless otherwise notified, all gifts received through this newsletter will be matched by the Circle and will be used to fund vital CF research projects. Now is an exciting time to give, as your gift to CFRI will be matched 1-to-1 by members of the Jessica Fredrick Memorial CF Research Challenge Circle, thereby doubling the impact of your donation! Those with CF spend hours each day trying to slow the inevitable progression of the disease. In addition to lung disease, many cope with liver issues, diabetes, pancreatic insufficiency, and other complications. We still have much more work to do to improve and save the lives of our loved ones. But we cannot do it without you. Please give today and help us match the Circle’s fund so that we can bring hope to those with CF and their loved ones. Working together, with an indomitable will, we can inspire hope and find a cure. To contribute to the Jessica Fredrick Memorial CF Research Challenge Circle, please call 650.404.9975, or email cfri@cfri.org 6 CFRI Gives Thanks to Members of the Jessica Fredrick Memorial CF Research Challenge Circle The Elizabeth Nash Foundation Millward Brown, Inc. Sereno Group of Willow Glen Spiritus Project (Robert Link) John and Sallie Best Randall Colombo Michael and Pat Flynn Suzanne Freiley Bill and Vicci Hult Shannon Jorgenson Sue and Marc Landgraf Fred and Linda Milanovich Doug and Robin Modlin Frank S. Morsman, Jr. Marvin and Bune Primack If you want your donation to honor or remember someone special, please include the person’s name and address with your donation. At your request, we will send an acknowledgement of your gift to the person you designate. Please mail your contributions to: CFRI 1731 Embarcadero Road Suite 210 Palo Alto, CA 94303 CauseVox Research Campaign Hits 100% of Goal! Thanks to our generous donors, CFRI’s crowdfunding campaign to raise $5,000 in support of CF research was a success. Contributions made through the 30-day campaign were matched one-to-one by members of CFRI’s Jessica Fredrick Memorial CF Research Challenge Circle, thereby doubling the impact of each gift. CFRI is grateful to all who supported this important campaign. cfri | Summer 2015 January 1, 2015 — April 30, 2015 Henry Aulus Allison Gianna R. Altano Ginni Andres David Armknecht Jodi Armknecht Ann M. Baldwin Gloria Bellefleur Anne C. Beltrame Kristina Benson Ezequiel Bondy-Villa Lara Borowski Wendy Bosarge Alicia Brogle Sonya Chartrand Gail Christensen Ryan Coelho K. Cole Robert Cowden Rachel Crocker Bette Dambacher Charles Delgado Neva L. DeVore Steven Elconin Jessica A. Fredrick Mildred Fredrick Jade Frota R. M. Gabbard John “Jack” Girvin Jenise Giuliano Lawrence “ Larry” Goldberg Diana Goodman Heather E. Gottlieb Bill Haig Kathleen Halsey Warren A. Harden Sharon Hill Sean Hyland James A. Irwin Jason Jean Jordan Jean Alec Jenkins Kathy Judge Peter Judge Blake Kelly Norman King Lori Kipp Bridget Klein Kelly M. Knight Raymond Kulik Al Ladendorf Dawn Longero Justine M. Marocco Jason Marshall Jean Marshall Jordan Marshall Frances Martinelli Nahara Mau David McAfee Juanita McDonald Robert McFadden Helen McGowan Barbara A. McKee Ronald McMullen Arthur Messinger Loretta Morris Lee Nichols Gretchen Nordlund Thaddeus Novak Michele D. Olson Jennifer Ortman Dellene Ott Lisa Pearne Paula Peterson Barbra A. Petitt Kevin Pira Jon Prater Timothy Prater Richard Richards Peter Riddle Tom Rolefson Edith Schlotterbeck Joseph M. Sinnaeve Tammy Smerber Dawn Smith Yolanda “Lindy” Stagnaro Dunn Anabel M. Stenzel Robin Stephenson Robert C. Stewart Charlie Stockley David Stuckert Laurie Stuckert Delinda Syme Bill Tidball Louis Trigueiro Ralph Turner Erik Van Ness Tom Walton Tara Weir Dawn Wernli Ray Wilkens Sharon Williams Kelly A. Wilson Cynthia Witman Hannah Mitchell Anna Modlin Kate Nelson Jessica Nett Scott Parks Brie Peters Jereme Pierce Hollie Pratt Robyn Primack Paul Quinton Pauline Richard Rebecca Roanhaus Kaeti Roberts Ann Robinson Elizabeth Rogers Taylor Rolefson Alanah Rosenbloom Corey Sarkis Lindsay Schwab Ken Semel Gina Serrato Rachel Silver Matt Spadia Alma G. St. Lawrence Rebecca Swank Heidi Tegner Geyer Adam Thompson Katherine Thompson Pina Toccagino Carol D. Umber Devin Wakefield Scott Wakefield Christopher Walton Jason Webster Pamela Whitehurst Kareese Wilson Jeff Wine Nina Wine January 1, 2015 — April 30, 2015 Chelsa Aboud Sadie Anderson Kyle Baker Susie Baldwin Bridget Barnes Lucy Barnes Brandon Begin Aidan Biggar Oliver Biggar Erin Brassfield Lauren Catron Maureen Coffy Michelle Compton Barbara H. Curry Cheri DeWilde Tess Dunn Jessica Eller Daniel Ellett Thomas Evans cfri | Summer 2015 Emily Fredrick Sean Gallagher Mark E. Gerow Larissa Giuliano Mark Glisson Elyse E. Goldberg Jen Goodwin Elsie Hamer Alex Hampton Liz Hampton Kerry Harrison George M. Hawley Christian Heavner Tyler Heavner Kathleen G. Henshaw Melanie Henshaw James Heyboer Shawn Hidy Vincent Holmquist Thomas Horal Bill Hult Deion Jefferson Carroll P. Jenkins Michelle Jones Peggy B. Jones Stan Kelly Franny Kiles Kristin Kovolinka Santosh M. Krishnan Daniel Lagasse Douglas Lagasse Kody Lawrence Joseph Librers Alyson Lowery Emily F. Lucas Larissa Marocco Eric Marten Carly L. McReynolds 7 CFRI’s Partners in Living Initiative: Celebrating A Mind-Body Success By Siri Vaeth Dunn, MSW The Partners in Living Initiative – A Holistic Approach to Life with Cystic Fibrosis (CF), was designed to help members of the CF community achieve optimal physical and mental wellbeing, in recognition of their significantly higher rates of depression and anxiety, which if left unaddressed are detrimental to overall health. Launched in January 2015, the pilot six-month multidisciplinary initiative – funded by a $50,000 new program grant from Vertex Pharmaceuticals – successfully strengthened the link between good mental health and a better physical quality of life for those who participated. program continues until August, or until all funds are expended. CFRI’s monthly peer-to-peer support group for caregivers is held in Palo Alto, California, but participants may phone in, whether they are in California, New York, or states in between. The support group is held on the fourth Tuesday of each month at 7:00 pm PST. CFRI’s Mindfulness-Based Stress Reduction (MBSR) course, led by Dr. Julie Desch, combined meditation, body awareness and yoga to help people living with CF – including caregivers – cope with anxiety, depression, stress, and chronic pain. People A very successful component of the initiative from across the nation participated in this has been the CF Quality of Life Program, a online class, and the number of enrollees Living Legacy of Peter Judge, in which CFRI far exceeded our goal. covers the cost of individual counseling for The last component of the Partners in Living those with CF and their parents/caregivers, regardless of where they live in the U.S. This Initiative was the offering of an exciting NNIVERSARY G S 40th A ’ ALA I R CF A MAGICAL EVENING at CAROLANDS September 25, 2015 | 7:00 pm – 10:00 pm CF Pediatric Education Conference in May. Spanish interpretation was provided, and the conference was filmed and translated, with the resulting DVDs distributed free of charge to CF pediatric centers. The Partners in Living Initiative has had a measurable impact upon participants, as outcome evaluations demonstrate that participation in these programs has improved participants’ wellbeing and quality of life. Tickets are $300 per person, and expected to sell out. Sponsorships are available. A Magical Evening at Carolands is a celebration of four decades of progress in cystic fibrosis (CF) research. Enjoy gourmet small plates, delectable desserts, fine wine, fabulous entertainment (Tammy Nelson of Beach Blanket Babylon), the “CF Champion” award presentation, and an exciting live auction. All funds raised will support CFRI’s research and education programs, to improve the lives of those with cystic fibrosis. For more information, contact Siri Vaeth Dunn 650.404.9445 | svdunn@cfri.org Sponsored by • Vertex Pharmaceuticals • NBC Bay Area • AbbVie • Chiesi USA Those with CF cannot attend if they have: Had a confirmed positive culture for Burkholderia cepacia; Have cultured MRSA within the past 2 years; Have had 2 or more consecutive positive cultures for Nontuberculous mycobacteria in the past 12 months; or currently culture positive for any bacteria resistant to all antibiotics. 8 cfri | Summer 2015 CF Summer Retreat: Animate progressed she sought a Your Summer! place where she could connect By Isa Stenzel Byrnes, MSW / MPH CFRI is excited to offer its 20th CF Summer Retreat (formerly the CFRI Teen and Adult Retreat),“Animate Your Summer!,” from August 2–9th, 2015 at Vallombrosa Center in Menlo Park. CFRI is a pioneer in creating safe places for CF patients to socialize by following a strict cross infection policy. The retreat has been an emotional and social sanctuary for many young adults with CF over the years. Here they can exhale, be themselves, open up, and share real stories about what it’s like to grow up and live with cystic fibrosis. Using educational seminars, expressive arts workshops, and daily exercise sessions such as Zumba® and yoga, the CF Summer Retreat helps adults expand their healing toolbox beyond the day-to-day medical regimen. The retreat encourages CF adults to live better with cystic fibrosis by becoming empowered in self-management of all aspects of CF care. The CF Summer Retreat is indeed powerful medicine. The 2015 CF Summer Retreat honors the memory of Kriss Benson, a beautiful 38-yearold woman who was a long-time retreat attendee, often accompanied by her loving husband, Arthur Yang. Kriss grew up in isolation from CF peers, but as her disease with others going through the same experience. Once Kriss attended, she said, “the light bulb went on, and I knew I needed CF friends to help me survive.” Kriss became such a passionate supporter that she joined the retreat committee, feverishly helping out with graphic designs, scavenger hunts, arts and crafts, and other creative activities. CF retreat helped Kriss cope with the demands of advanced-stage CF. In return, the retreat community received a fun, Kriss Benson with her husband, Arthur Yang loving, creative, authentic, and dedicated role model to helping others experience it also. She would inspire us to live our best lives with CF. be so happy to know that the Memorial Sadly, Kriss passed away in September, Fund will be providing assistance for others 2014. Her family has generously established to attend for years to come.” The entire CF the Kriss Benson Memorial Retreat Fund to Summer Retreat community misses Kriss help those with financial limitations attend tremendously and is deeply appreciative of the retreat free of charge. Kriss Benson’s the Benson family’s support. husband Arthur Yang shared that, “Kriss greatly benefited from the immeasurable We encourage those with CF – 18 years and older – to join us at this year’s CF Summer emotional support that the retreat Retreat. Animate yourselves! provided, and she was passionate about CFRI’s 2015 CF Summer Retreat August 2 – 9, 2015 | Vallombrosa Retreat Center, Menlo Park, California The CF Summer Retreat provides a safe environment that enhances positive coping skills, social support, and education for people who share common experiences with CF. Adults with CF, 18 years and older, their family members, friends, and health care providers may attend. Please join us! Registration: $85 per participant/week; $15 per participant or visitor/day Accommodations: $55 per participant/night Scholarships are available. To ensure good health for all, please use proper hygiene practices. All participants/guests with CF must comply with CFRI’s Infection Control Guidelines. For specifics, please go to www.cfri.org. Sponsored by Genentech and Gilead Sciences cfri | Summer 2015 For more information go to www.cfri.org or call 1.855.cfri.now 9 Measuring CFTR Function in Humans Continued from front cover Tests of efficacy require that a symptom of the disease, almost always the ‘FEV1’ test of lung function, must show a significant difference between large groups of subjects on or off the medicine. This takes time, and such tests are becoming more difficult because improved clearance and antibiotic treatment regimens are slowing the decline in lung function in people with CF to such an extent that it would take many years to see a difference. Fortunately, it is now possible to measure CFTR function accurately in humans by using a special sweat rate test. Our sweat glands produce sweat in two ways. One pathway depends linearly on CFTR function. We call this kind of sweating C (for CFTRdependent) sweating. C-sweat rates are zero in CF and are half normal in carriers. This linear readout of CFTR function is highly unusual and is not seen in most other tests of CFTR function – for example, FEV1 and conventional sweat chloride measures are essentially the same in carriers and healthy controls. A second pathway does not require CFTR and appears to be normal in people with CF. We call this kind of sweating ‘M-sweating,’ for the drug that we use to produce it. Our test measures both kinds of sweating in each of about 50 sweat glands in a little patch of skin. By comparing the two types of sweating in the same glands, we control for variables such as gland size. And because we can return to the same identified glands over and over again in different conditions, we quickly amass large data sets that allow us to quantify even small changes in CFTR function. We report an individual’s CFTR function as the percent of average function in a population of healthy control subjects. Interestingly, we find a large range of values in our healthy control subjects, as though they too were expressing a range of CFTR function. Healthy people are known to express a range of CFTR mRNA transcripts (the molecules that let the cell make CFTR protein), but no prior test has been sensitive enough to detect corresponding differences in CFTR function. With support from a CFRI New Horizons Grant and from the CFFT Sweat Measures Consortium, we are measuring C- and M-sweating in a large cohort of healthy subjects, and will attempt to correlate those rates with CFTR transcript levels, as well as in selected individuals the DNA sequence of CFTR. The results will further our goal of providing a fast and accurate assessment of CFTR function over its entire range, thus enabling more rapid human testing of CFTR-directed therapeutics. Mother’s Day is Every Day at CFRI! Our heartfelt thanks go out to those of you who participated in CFRI’s biggest fundraiser of the year, the annual Mothers’ Day Tea, and helped brighten the future for someone living with cystic fibrosis. Since Mother’s Day is every day at CFRI, 10 we still need your help to reach our goal of $175,000 to support our promising research, education and outreach to the CF community. If you have not participated and would like to invite your friends and family to savor a cup of tea while reflecting on a loved one who lives with cystic fibrosis, please contact us at CFRI and we will provide you with everything you need, including beautiful invitations, teabags and information about CFRI. For those of you who wish to participate in a virtual tea, go to http://tinyurl.com/ousfddj Save the Dates CFRI 28th National CF Family Education Conference Partners in Progress July 31 – August 2, 2015 Sofitel San Francisco Bay Redwood City, CA Register Now! CFRI CF Summer Retreat August 2 – 9, 2015 Vallombrosa Center Menlo Park, CA Register Now! Cystic Fibrosis Benefit Golf Tournament at Pasatiempo Golf Course August 3, 2015 Santa Cruz, CA Register Now! CFRI’s 40th Anniversary Gala A Magical Evening at Carolands September 25, 2015 Hillsborough, CA Purchase Tickets Now! CF Discovery Series September 8, 2015 October 13, 2015 November 10, 2015 6:00 pm – 7:30 pm PST Crowne Plaza Cabana Hotel Palo Alto, CA Livestreamed! CF Caregivers Support Group Fourth Tuesday of Every Month 7:00 pm – 9:00 pm PST CFRI office, Palo Alto, CA Or participate by phone Please RSVP For more information about any of these events, please call 1.855.cfri.now (1.855.237.4699) or email cfri@cfri.org cfri | Summer 2015 A Powerful Embrace: CFRI’s Retreat for Mothers of Those with CF By Jane Mitchell A group of 24 women gathered for CFRI’s first retreat for mothers of children and adults with CF, at the Vallombrosa Retreat Center in Menlo Park, California, over the weekend of April 17. Robin Modlin, MA, mother of an adult daughter with CF and long-time CFRI volunteer, brought the idea for the retreat to CFRI, and “Embrace” was born. The theme, “Embrace,” was selected by Robin to encourage mothers to, “embrace the journey, embrace the community, embrace yourself.” Mothers (and one adult sibling) traveled from several states to participate. Our children ranged in age from three years to 36; several mothers had recently lost their daughters. Vallombrosa provided the perfect backdrop for sharing personal stories and experiences along with our hopes and aspirations. CFRI offered a weekend full of activities, including a moving evening of diagnosis stories, SoulCollage®, yoga, inspiring presentations from experts, labyrinth walking, meditation, and a powerful journaling workshop led by Isabel Stenzel Byrnes, MSW, MPH. It was a joyous time on Saturday evening when singer-songwriter Nancy Cassidy performed Embrace Retreat participants that we will now continue the CF journey together. The one question asked by every mother who attended CFRI’s Embrace was, Embrace is the perfect description for what “When can we do this again?” each of us experienced, as we shared our unique bond of motherhood. As goodbyes Embrace was generously sponsored by Genentech and Vertex, with additional were shared on Sunday afternoon, there was tremendous mutual excitement for this support from Modern Health Specialty newly found community and the knowledge Pharmacy and Actavis. at our evening celebration. The beautiful music entranced everyone. Become a CFRI Partner in Living! Your Support Can Change Lives •ATTEND A CFRI FUNDRAISING EVENT No matter what type of event you enjoy, we have one for you! In addition to the Magical Evening at Carolands, we have concerts, golf tournaments, and other events that are posted on our website, Facebook page, and weekly eBlasts. Have fun while supporting CFRI! •COFFEE FOR A CURE Not a tea drinker? How about coffee? Through Coffee for a Cure, you invite your family members, friends and colleagues to join you for a virtual cup of coffee, while supporting CFRI and its vital programs for the CF community. •GIVING GIFTS OF STOCK TO CFRI Giving a gift of appreciated stock to CFRI is easy and rewarding. You will not pay capital gains tax on stock that has appreciated over the years. You will receive an income tax charitable deduction for the fair market value of the stock on the date of the gift. If you hold stock certificates that you wish to donate to CFRI, contact us for instructions on how to complete the transaction. •HOLD YOUR OWN FUNDRAISER: 40 Years – 40 Events! Big or small, we appreciate them all! Zumbathons, concerts, cfri | Summer 2015 cupcake sales, dinner parties with a special guest of honor, bocce ball tournaments – come up with an idea and we will support you! • TRIBUTES IN HONOR OF & IN MEMORY OF Any gift to CFRI can be made in honor or in memory of a loved one. Your loved one’s name will appear in our newsletter, CFRI Community, and if requested, an acknowledgement will be sent to the person you designate. •CHARITABLE PLANNED GIVING Planned giving offers benefits for donors that often include increased income and substantial tax savings, while providing the opportunity to meet your philanthropic goals & provide positive tax benefits. • VEHICLE DONATIONS If you have a car, boat, recreational vehicle or motorcycle that you no longer need, please consider donating your vehicle to CFRI. This contribution is tax-deductible, and we will coordinate the transfer of property. Visit our website for details on making a donation. For more information please contact Mary Convento at 650.404.9975 or mconvento@cfri.org 11 Nonprofit Organization U.S. Postage PAID Palo Alto, CA 1731 Embarcadero Road . Suite 210 Palo Alto, California 94303 Permit #24 Change Service Requested CFRI’s mailing list is confidential. We do not sell our list, nor do we give out any names or addresses under any circumstance. CFRI Mission Cystic Fibrosis Research, Inc. exists to fund research, to provide education and personal support, and to spread awareness of cystic fibrosis, a life-threatening genetic disease. CFRI Vision As we work to find a cure for cystic fibrosis, CFRI envisions informing, engaging and empowering the CF community to help all who have this challenging disease attain the highest possible quality of life. CFRI’s 28th National Cystic Fibrosis Family Education Conference Partners in Progress July 31 - August 2, 2015 Sofitel San Francisco Bay Redwood City, CA Our annual conference brings together experts in the field of CF to provide the latest updates in research and care to our diverse CF community. Speakers: Tess Dunn – San Jose, California • Chris Kvam, Esq – Rochester, New York Martha Markovitz, LCSW – University of Southern California • Kimberly Morse, LCSW – Children’s Hospital Los Angeles • Elika Rad, MS, RN, NPC – Stanford Hospital & Clinics Margaret Rosenfeld, MD – Seattle Children’s Hospital • Scott Russell, DPT – University of Southern California • Greg Sawicki, MD, MPH – Boston Children’s Hospital Lisa Saiman, MD – Columbia University Medical Center • Beth Sufian, Esq – Houston, Texas Anna Tsang, MSO – St. Michael’s Hospital, Toronto Early Bird Registration (on or before 6/30/15) - $180 per person Regular Registration (after 6/30/15) - $215 per person Registration includes meals, reference materials, and access to presentations & support groups. To ensure good health for all, please use proper hygiene practices. All participants/guests with CF must comply with CFRI’s Infection Control Guidelines. See www.cfri.org for specifics. For more information, visit www.cfri.org or call 1.855.cfri.now Visit our website at: www.cfri.org for more information about us and about cystic fibrosis. Call toll free: 1.855.cfri.now Sponsored By: AbbVie • Boomer Esiason Foundation • Chiesi USA • Genentech Gilead Sciences, Inc. • Novartis • Vertex Pharmaceuticals For their generous support of CFRI Community, special thanks to: Chiesi USA • Genentech • Gilead Sciences, Inc. • Vertex Pharmaceuticals Cystic Fibrosis Research, Inc. a 501(c)(3) nonprofit organization Federal EIN# 51-0169988